Cited by 3,651Nanoparticle-Based Drug DeliveryRNA Interference and Gene DeliveryDendrimers and Hyperbranched Polymers

Strategies in the design of nanoparticles for therapeutic applications

Petros, Robby A., DeSimone, Joseph M.·2010·Nature Reviews Drug Discovery

Abstract

Engineered nanoparticles have the potential to revolutionize the diagnosis and treatment of many diseases; for example, by allowing the targeted delivery of a drug to particular subsets of cells. However, so far, such nanoparticles have not proved capable of surmounting all of the biological barriers required to achieve this goal. Nevertheless, advances in nanoparticle engineering, as well as advances in understanding the importance of nanoparticle characteristics such as size, shape and surface properties for biological interactions, are creating new opportunities for the development of nanoparticles for therapeutic applications. This Review focuses on recent progress important for the rational design of such nanoparticles and discusses the challenges to realizing the potential of nanoparticles.

Integrity signals

Registry

Crossref · 10.1038/nrd2591

Cites

176 of 176 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Liposomes application and lipid-based drug delivery systems have been narrowed due to attained drug resistance and poor targeting.

    “Nevertheless, liposomes application and lipid-based drug delivery systems have been narrowed due to attained drug resistance and poor targeting [98,99].”

    From Recent Advances in Nanomicelles Delivery Systems. (2020) · cites this paper as [98]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Petros, R. A., & DeSimone, J. M.
Affiliations
  • University of North Texas (US)
  • University of North Carolina at Chapel Hill (US)
Venue
Nature Reviews Drug Discovery
Published
2010-07-09
Volume
9
Issue
8
Pages
615-627
ISSN
  • 1474-1776 (ISSN-L)
  • 1474-1784
OpenAlex
W1975088956
Cited by
3,651
References
176
Citations by year
2026: 93 · 2025: 134 · 2024: 172 · 2023: 171 · 2022: 204 · 2021: 214 · 2020: 272 · 2019: 274 · 2018: 270 · 2017: 356 · 2016: 315 · 2015: 331 · 2014: 278 · 2013: 240 · 2012: 197
FWCI
8.91
Type
journal article
Language
en
Open access
closed
Locations
  • Nature Reviews Drug Discovery (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5p01gm059299-10)
  • National Cancer Institute (U54CA119343)
  • National Institute of General Medical Sciences (P01 GM-059299)
Topics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
Keywords
nanoparticles, nanotherapeutics, targeted drug delivery, nanoparticle size, nanoparticle morphology, surface properties, species interactions, biological barriers
MeSH terms
Pharmaceutical Preparations, Humans, Particle Size, Surface Properties, Drug Design, Drug Delivery Systems, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review